Corrigendum: Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation

Vinai Bhagirath; Tanya Kovalova; Jia Wang; Lizhen Xu; Shrikant I Bangdiwala; Martin O'Donnell; Ashkan Shoamanesh; Jackie Bosch; Rosa Coppolecchia; Tatsiana Vaitsiakhovich; Frank Kleinjung; Hardi Mundl; John Eikelboom

doi:10.1055/s-0044-1788303

Corrigendum: Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation

TH Open. 2024 Jul 29;8(1):e1. doi: 10.1055/s-0044-1788303. eCollection 2024 Jan.

Authors

Vinai Bhagirath^{1

2}, Tanya Kovalova¹, Jia Wang¹, Lizhen Xu¹, Shrikant I Bangdiwala^{1

2}, Martin O'Donnell^{1

3}, Ashkan Shoamanesh^{1

2}, Jackie Bosch², Rosa Coppolecchia⁴, Tatsiana Vaitsiakhovich⁵, Frank Kleinjung⁵, Hardi Mundl⁶, John Eikelboom^{1

2}

Affiliations

¹ Population Health Research Institute, Hamilton, Ontario, Canada.
² McMaster University, Hamilton, Ontario, Canada.
³ University of Galway, Galway, Galway, Ireland.
⁴ Bayer US LLC, Whippany, New Jersey, United States.
⁵ Bayer AG, Berlin, Germany.
⁶ Bayer AG, Wuppertal, Germany.

Abstract

[This corrects the article DOI: 10.1055/a-2259-1134.].

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ).

Publication types

Published Erratum